(19)
(11) EP 3 297 704 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.03.2020 Bulletin 2020/10

(45) Mention of the grant of the patent:
08.01.2020 Bulletin 2020/02

(21) Application number: 16723496.2

(22) Date of filing: 17.05.2016
(51) International Patent Classification (IPC): 
A61M 1/36(2006.01)
(86) International application number:
PCT/GB2016/051415
(87) International publication number:
WO 2016/185197 (24.11.2016 Gazette 2016/47)

(54)

CONTROL SYSTEM

STEUERUNGSSYSTEM

SYSTÈME DE COMMANDE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 21.05.2015 GB 201508731
15.09.2015 GB 201516331

(43) Date of publication of application:
28.03.2018 Bulletin 2018/13

(73) Proprietor: Spectrum Medical Ltd.
Gloucester GL2 9QL (GB)

(72) Inventor:
  • TURNER, Stephen
    Gloucester Gloucestershire GL2 9QL (GB)

(74) Representative: Somervell, Thomas Richard 
Marks & Clerk LLP Alpha Tower Suffolk Street Queensway
Birmingham B1 1TT
Birmingham B1 1TT (GB)


(56) References cited: : 
EP-A1- 3 165 246
WO-A2-2012/141756
US-A1- 2012 130 299
 EP-A1- 3 167 920
US-A- 3 890 969
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).